These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6821551)

  • 1. Appearance of strong transplantation antigens in non-immunogenic lymphoma following drug-treatment in vivo.
    Fioretti MC; Romani L; Bonmassar A; Taramelli D
    J Immunopharmacol; 1980; 2(2):189-212. PubMed ID: 6821551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3,3'-dimethyl-1-triazeno)imidazole-4-carboxamide.
    Contessa AR; Bonmassar A; Giampietri A; Circolo A; Goldin A; Fioretti MC
    Cancer Res; 1981 Jun; 41(6):2476-82. PubMed ID: 7016315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of the immunogenic properties of a radiation-induced mouse lymphoma following treatment with antitumor drugs.
    Bonmassar E; Testorelli C; Franco P; Goldin A; Cudkowicz G
    Cancer Res; 1975 Aug; 35(8):1957-62. PubMed ID: 1149019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of the immunogenic properties of K36 lymphoma treated in vivo with 5(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC).
    Bonmassar A; Frati L; Fioretti MC; Romani L; Giampietri A; Goldin A
    Eur J Cancer (1965); 1979 Jul; 15(7):933-9. PubMed ID: 488153
    [No Abstract]   [Full Text] [Related]  

  • 5. Susceptibility of murine lymphoma cells treated with 5-(3,3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide to NK-mediated cytotoxicity in vitro.
    Romani L; Migliorati G; Bonmassar E; Fioretti MC
    Int J Immunopharmacol; 1983; 5(4):299-306. PubMed ID: 6629590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.
    Testorelli C; Archetti YL; Aresca P; Del Vecchio L
    Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo.
    Romani L; Fioretti MC; Bonmassar E
    Transplantation; 1979 Sep; 28(3):218-22. PubMed ID: 494379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies.
    Parmiani G; Invernizzi G
    Int J Cancer; 1975 Nov; 16(5):756-67. PubMed ID: 52628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-mediated changes of tumour cell immunogenicity and antigenicity.
    Puccetti P; Romani L; Taramelli D; Bonmassar E; Fioretti MC
    Int J Tissue React; 1982; 4(3):189-99. PubMed ID: 6183194
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional studies of H-2k-like epitopes on DTIC treated and untreated L1210 (H-2d) clones.
    Marelli OE; Franco P; Labeta MO; Festenstein H
    J Immunogenet; 1989; 16(4-5):373-80. PubMed ID: 2639909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation resistance of drug-treated hybrid or allogeneic mice against murine lymphomas. I. Immunopharmacology studies.
    Bonmassar A; Riccardi C; Rivosecchi-Merletti P; Goldin A; Bonmassar E
    Int J Cancer; 1980 Dec; 26(6):819-29. PubMed ID: 6971268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-mediated antigenic changes in murine leukemia cells: antagonistic effects of quinacrine, an antimutagenic compound.
    Giampietri A; Fioretti MC; Goldin A; Bonmassar E
    J Natl Cancer Inst; 1980 Feb; 64(2):297-301. PubMed ID: 6928222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 14. T cells must recognize tumor antigen in association with self-MHC antigen.
    Lannin DR; Yu S; McKhann CF
    Transplant Proc; 1981 Mar; 13(1 Pt 2):739-41. PubMed ID: 6168072
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lymphoma growth in the spleen and liver of lethally irradiated mice.
    Iorio A; Campanile F; Neri M; Spreafico F; Goldin A; Bonmassar E
    J Immunol; 1978 May; 120(5):1679-85. PubMed ID: 659871
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural resistance of mice pretreated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) + cyclophosphamide (Cy) against virus-induced lymphoma cells.
    Campanile F; Iorio AM; Bonmassar E
    Int J Immunopharmacol; 1984; 6(4):251-8. PubMed ID: 6480192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased immunogenicity of murine lymphoma cells following exposure to gamma rays in vivo.
    Guadagni F; Roselli M; Fuggetta MP; Perno CF; Goldin A; Giuliani A
    Chemioterapia; 1984 Dec; 3(6):358-64. PubMed ID: 6529777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunodepressive and hematotoxic activity of imidazole-4-carboxamide,5-(3,3-dimethyl-1-triazeno) in mice.
    Vecchi A; Fioretti MC; Mantovani A; Barzi A; Spreafico F
    Transplantation; 1976 Dec; 22(6):619-24. PubMed ID: 795112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro lymphocyte stimulation and the generation of cytotoxic lymphocytes with drug-induced antigenic lymphomas.
    Testorelli C; Franco P; Goldin A; Nicolin A
    Cancer Res; 1978 Mar; 38(3):830-4. PubMed ID: 75062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.